Sponsors (24)
The bill maintains and extends federal support and program continuity for vector-borne disease surveillance, research, and training through 2030—benefiting state/local public health and hospitals—but increases federal spending and shifts language that could centralize decision-making and reduce transparency for external partners.
State and local health departments, hospitals, and public-health researchers will retain federal funding and authorization through 2030 for surveillance, response, regional centers of excellence, and national strategy activities addressing tick- and vector-borne diseases.
Local and state public-health agencies and their staff will avoid abrupt expiration of grants and programs—reducing disruption to ongoing projects, planning efforts, and personnel because authorizations are extended.
State and local governments, nonprofits, and external partners may see more centralized decision-making because replacing 'in coordination with' with 'acting through' could concentrate authority within HHS and limit explicit collaborative roles.
Members of the public may face reduced transparency about which experts influence program decisions because a specific advisory-group citation is replaced with the broader phrase 'appropriate individuals.'
Taxpayers could bear increased long-term federal spending because extending program authorizations through 2030 raises federal outlays without identified offsets.
Based on analysis of 2 sections of legislative text.
Extends federal authorization for national strategy, centers of excellence, and support to health departments for vector-borne diseases and adjusts coordination wording for 2026–2030.
Official title: Reauthorize the Kay Hagan Tick Act, and for other purposes.
Introduced July 23, 2025 by Susan Margaret Collins · Last progress August 6, 2026
Extends and updates existing federal programs addressing tick-borne and other vector-borne diseases by changing coordination language and renewing authorized program years from 2026 through 2030. The bill makes small wording adjustments to how federal agencies and partners work together and prolongs the national strategy, regional centers of excellence, and health-department support previously authorized for 2021–2025 so those activities may continue through 2030.